Simplex Trading’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Simplex Trading’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-538	Closed	-$52K	–	11063
2022 Q2	$52K	Sell	538 -11	-2%	-$275	﹤0.01%	6453
2022 Q1	$20K	Sell	549 -5	-0.9%	-$180	﹤0.01%	8273
2021 Q4	$19K	Buy	554 +133	+32%	+$7.01K	﹤0.01%	8436
2021 Q3	$36K	Buy	421 +1	+0.2%	+$71	﹤0.01%	7926
2021 Q2	$36K	Buy	420 +417	+13,900%	+$39.7K	﹤0.01%	8055
2021 Q1	$33K	Buy	+3	New	+$333	﹤0.01%	7048
2019 Q4	–	Sell	-2	Closed	-$16K	–	8085
2019 Q3	$16K	Buy	2 +1	+100%	+$217	﹤0.01%	5975
2019 Q2	$26K	Buy	+1	New	+$353	﹤0.01%	5405
2019 Q1	–	Hold	0	–	-$1K	–	8006
2018 Q4	–	Hold	0	–	–	–	6810
2018 Q1	–	Hold	0	–	-$2K	–	7000
2017 Q4	–	Hold	0	–	–	–	5294
2017 Q3	–	Hold	0	–	–	–	4890
2016 Q4	–	Sell	-2	Closed	-$22K	–	6661
2016 Q3	$22K	Buy	2 +1	+100%	+$350	﹤0.01%	2886
2016 Q2	$20K	Buy	+1	New	+$360	﹤0.01%	2916

Other funds holding CSCI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Simplex Trading's CSCI Position: Q3 2022 in Review

Simplex Trading sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 328 shares — an estimated $6K sold.

Simplex Trading first reported a position in CSCI in Q2 2016 and held it in 13 quarters. The position peaked at $62K in Q3 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Simplex Trading reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 328 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $6K.
Simplex Trading first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2016 and held it in 13 quarters.
Simplex Trading's COSCIENS Biopharma Inc. Common Stock position peaked at $62K in Q3 2021.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.